# Over-Represented Senescent Keratinocytes in Hyperpigmented Spots Promote Melanocyte Activation via IGFBP3 and NGF

**Authors:** Tomohiro Hakozaki, Holly Rovito, Bradley B. Jarrold, John Snowball, Jiazhen Wang, Wenzhu Zhao, Timothy Laughlin

PMC · DOI: 10.3390/ijms262110724 · International Journal of Molecular Sciences · 2025-11-04

## TL;DR

Senescent keratinocytes in hyperpigmented spots activate melanocytes through IGFBP3 and NGF, contributing to pigmentation and offering new cosmetic targets.

## Contribution

Identifies keratinocyte senescence as a novel driver of melanocyte activation in hyperpigmentation via IGFBP3 and NGF.

## Key findings

- Senescent keratinocytes increase melanocyte dendricity and melanin synthesis through IGFBP3 and NGF.
- Skincare ingredients like sucrose dilaurate and niacinamide reduce secretion of these ligands.
- Transcriptomic analysis reveals IGFBP3 and NGF as key factors in melanocyte activation.

## Abstract

The occurrence and impact of cellular senescence on skin aging and hyperpigmentation is an ongoing area of exploration, encompassing both intrinsic and extrinsic stressors. Traditionally, research has focused on melanocyte and fibroblast senescence due to their slower turnover compared to keratinocytes. In this study, we identified the accumulation of p16, a senescence marker, in keratinocytes from biopsies of multiple spot types. We explored their impact using doxorubicin-induced senescent keratinocytes in vitro. Conditioned media from these senescent keratinocytes stimulated melanocyte dendricity, a hallmark of hyperpigmented spots. Transcriptomic analysis of senescent keratinocytes identified two key senescence-induced factors: Insulin-like Growth Factor-Binding Protein 3 (IGFBP3) and Nerve Growth Factor (NGF). IGFBP3 and NGF ligand treatment enhanced melanin synthesis by 33% and 17%, and dendricity by 23% and 14%, respectively, in human melanocyte cultures. These findings suggest that keratinocyte senescence contributes to spot formation by mediating melanocyte activation through IGFBP3 and NGF. Furthermore, we evaluated skincare ingredients such as sucrose dilaurate, glabridin, and niacinamide in neutral and low pH solutions, demonstrating their efficacy in reducing the secretion of these ligands, thereby offering potential cosmetic benefits. This study provides insights into the mechanisms of spot formation and highlights promising strategies for managing pigmentation disorders.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029]
- **Proteins:** IGFBP3 (insulin like growth factor binding protein 3), NGF (nerve growth factor)
- **Chemicals:** doxorubicin (PubChem CID 31703), sucrose dilaurate (PubChem CID 5484289), glabridin (PubChem CID 124052), niacinamide (PubChem CID 936)

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 3486] {aka BP-53, IBP-3, IBP3, IGFBP-3}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}
- **Diseases:** pigmentation disorders (MESH:D010859), hyperpigmentation (MESH:D017495)
- **Chemicals:** niacinamide (MESH:D009536), doxorubicin (MESH:D004317), melanin (MESH:D008543), sucrose (MESH:D013395), glabridin (MESH:C107601), dilaurate (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608426/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608426/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608426/full.md

---
Source: https://tomesphere.com/paper/PMC12608426